StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$48.22+0.22 (+0.46%)

Close on Nov 17, 2026Market cap $2.28BP/E 13.5Yield –

How the market prices Prestige Consumer Healthcare

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Prestige Consumer Healthcare trades at 13.5× its earnings, against a median of 15.3× since 2016 — on the cheap side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2016

Median 15.3×, today 13.5×

What Prestige Consumer Healthcare keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin53.5%vs 52.8%
Operating margin26.3%vs -42.9%
EBITDA margin29.2%vs -29.3%
Net margin15.6%vs -39.9%
Free cash flow margin21.3%vs -9.41%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity9.12%vs -53.5%
Return on assets4.30%vs -40.7%
Return on invested capital8.24%vs -32.4%
Return on capital employed6.57%vs -38.7%

How hard the assets work

Revenue per dollar of assets0.28vs 0.39
Inventory turns a year2.99vs 2.68
Revenue per employee$1.24Mvs $405.05K
Profit per employee$193.27Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $1.93B, or 6.0 times a year of EBITDA. That is 45.8% of the $4.21B it would cost to buy the business outright.

Total debt$2.02B
Cash and short-term investments$89.13M
EBITDA, trailing twelve months$322.53M
Free cash flow, trailing twelve months$235.36M

Leverage and liquidity

Debt to equity1.05vs 0.50
Debt to EBITDA6.26vs 3.42
Net debt to EBITDA5.98vs 2.33
Debt to free cash flow8.57vs 4.83
Current ratio3.23vs 3.28
Quick ratio1.80vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

1.60
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

4 of 9 tests passed

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Price $48.22Graham $57.01

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield7.53%vs -22.8%
Free cash flow yield10.3%vs -9.68%
Buyback yield5.32%vs -0.67%
Shareholder yield5.32%vs 0.00%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$41.7752-week low52-week high$71.07
50-day20-day$48.22200-day

The close sits 22% of the way up the 52-week range, 32.2% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

53
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

PBHS&P 500
PeriodPBHS&P 500DifferencePBH per yearS&P 500 per year
1 month-3.4%-4.0%+0.6 pts
3 months-3.6%-5.0%+1.3 pts
Year to date-21.8%+8.2%−30.1 pts
1 year-18.2%+11.2%−29.5 pts
3 years-17.3%+68.5%−85.8 pts-6.1%+19.0%
5 years-20.9%+67.3%−88.2 pts-4.6%+10.8%
10 years-4.2%+291.6%−295.8 pts-0.4%+14.6%

How much it moves

Volatility, 1 year38.1%vs 80.5%
Volume against its 90-day average1.06vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

4M PBH shares were sold short on Oct 30, 2026, up 7.1% from the previous report, or 9.09% of the shares available to trade. At recent volumes it would take 8.1 days to buy them back. Over the last 20 sessions, 59.3% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float9.09%vs 8.89%
Short interest as a share of all shares8.96%vs 6.30%
Days of volume to buy it back8.05vs 5.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20264,243,261+7.1%527,1658.1
Oct 15, 20263,962,178-14.7%546,5497.3
Sep 30, 20264,644,472-3.1%703,8496.6
Sep 15, 20264,794,058+4.6%507,4949.4
Aug 31, 20264,584,372+7.3%414,78911.1
Aug 14, 20264,270,738+11.8%686,8876.2
Jul 31, 20263,819,116+23.7%471,7378.1
Jul 15, 20263,087,049-3.9%464,2896.7
Jun 30, 20263,212,919+9.6%913,2403.5
Jun 15, 20262,932,124+18.4%638,8804.6
May 29, 20262,477,439-7.7%732,8283.4
May 15, 20262,683,766-8.1%965,5942.8

Every measure, in full

96 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 4, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$2.28B
$254.69M
Enterprise Value
$4.21B
$130.88M
PE Ratio
13.51
23.02
PS Ratio
2.07
3.66
PB Ratio
1.19
1.99
P/FCF Ratio
9.71
18.54
P/OCF Ratio
9.16
13.24

Enterprise valuationIndustry

EV / Sales
3.81
2.38
EV / EBITDA
13.06
16.00
EV / EBIT
14.52
18.86
EV / FCF
17.90
21.55

Share statisticsIndustry

Shares Change (YoY)
-3.62%
11.0%
Float
47M
49M
Shares Held by Insiders
1.44%
11.3%
Shares Held by Institutions
113.5%
56.3%

Short sellingIndustry

Short Interest
4M
–
Short Interest Change
7.09%
-0.80%
Short % of Float
9.09%
8.89%
Short % of Shares Outstanding
8.96%
6.30%
Days to Cover
8.05
5.13

Stock price statisticsIndustry

52-Week High
$71.07
–
52-Week Low
$41.77
–
20-Day Moving Average
$47.34
–
50-Day Moving Average
$47.29
–
200-Day Moving Average
$52.98
–
Average True Range (14)
$1.93
–
Price Change (1 Week)
7.23%
-7.83%
Price Change (1 Month)
-3.00%
-6.48%
Price Change (3 Months)
-6.70%
-26.6%
Price Change (6 Months)
3.83%
-22.2%
Price Change (YTD)
-21.8%
-25.6%
Price Change (1 Year)
-19.6%
-23.8%
Price Change (3 Years)
-17.3%
-32.9%
Price Change (5 Years)
-20.0%
-77.3%
Price Change (10 Years)
-1.83%
-66.7%
Average Volume (10 Days)
737,710
–
Average Volume (20 Days)
629,150
–
Average Volume (90 Days)
567,929
–
Relative Volume
1.06
0.86
Relative Strength Index (14)
52.9
40.3
Volatility (1 Year)
38.1%
80.5%

MarginsIndustry

Gross Margin
53.5%
52.8%
Operating Margin
26.3%
-42.9%
Profit Margin
15.6%
-39.9%
EBITDA Margin
29.2%
-29.3%
FCF Margin
21.3%
-9.41%

Returns on capitalIndustry

Return on Equity (ROE)
9.12%
-53.5%
Return on Assets (ROA)
4.30%
-40.7%
Return on Invested Capital (ROIC)
8.24%
-32.4%
Return on Capital Employed (ROCE)
6.57%
-38.7%

Financial positionIndustry

Current Ratio
3.23
3.28
Quick Ratio
1.80
2.37
Debt / Equity
1.05
0.50
Debt / EBITDA
6.26
3.42
Debt / FCF
8.57
4.83
Net Debt / EBITDA
5.98
2.33

GrowthIndustry

Revenue Growth (YoY)
-1.36%
5.68%
Net Income Growth (YoY)
-19.2%
-31.1%
EPS Growth (YoY)
-16.2%
-25.8%
FCF Growth (YoY)
-12.1%
3.26%
Revenue Growth (3Y CAGR)
-1.17%
2.25%
Revenue Growth (5Y CAGR)
2.91%
6.41%
EPS Growth (5Y CAGR)
3.77%
3.69%

EfficiencyIndustry

Asset Turnover
0.28
0.39
Inventory Turnover
2.99
2.68
Revenue Per Employee
$1.24M
$405.05K
Profits Per Employee
$193.27K
-$704.12K
Employee Count
890
75

Income statement (TTM)Industry

Revenue
$1.10B
$58.79M
Gross Profit
$591.44M
$103.58M
Operating Income
$290.17M
-$21.49M
Net Income
$172.01M
-$22.47M
EBITDA
$322.53M
-$17.14M
EPS (Diluted)
$3.57
-$0.83

Balance sheetIndustry

Total Debt
$2.02B
$114.91M
Net Cash (Debt)
-$1.93B
$15.31M
Net Cash Per Share
-$40.71
$0.72
Equity (Book Value)
$1.92B
$49.40M
Book Value Per Share
$40.46
$1.45
Tangible Book Value
-$1.98B
$23.58M
Working Capital
$343.01M
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
$249.40M
-$12.17M
Capital Expenditures
-$14.04M
-$1.02M
Free Cash Flow
$235.36M
-$20.44M
FCF Per Share
$4.97
-$0.42

Dividends and yieldsIndustry

Earnings Yield
7.53%
-22.8%
FCF Yield
10.3%
-9.68%
Buyback Yield
5.32%
-0.67%
Shareholder Yield
5.32%
0.00%

Taxes and interestIndustry

Income Tax
$62.25M
$77.43K

Scores and fair valueIndustry

Graham Number
$57.01
$19.07
Graham Upside
18.2%
-47.6%
Altman Z-Score
1.60
0.12
Piotroski F-Score
4
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?